World Stem Cell Summit 2018 in Miami Solidifies Regenerative Medicine as the Future of Healthcare

Miami, FL – January 30, 2017 – The international regenerative medicine community concluded a week sharing breakthroughs, facing challenges and developing collaborations at the  13th World Stem Cell Summit (WSCS) at the Hyatt Regency Miami, January 22-26, 2018. The cure and treatment-focused meeting featured presentations on miraculous innovations in identifying the causes of disease, growing […]

Read more

Joe and Jill Biden among several honored at World Stem Cell Summit gala

By Jessica Barrios South Florida News Service (Photo courtesy Howard Miller) MIAMI – January 25, 2018 –  Greg Simon, president of the Biden Cancer Initiative gives an acceptance speech on behalf of the Bidens. Former Vice President Joe Biden and Dr. Jill Biden were among several leaders, innovators and professionals in the regenerative medicine field […]

Read more

Interview: Dr. Anthony Atala discusses the future of regenerative medicine

By Nick Rodriguez South Florida News Service (Photo credit: Nick Rodriguez)MIAMI-January 25, 2018 – Dr. Anthony Atala, director of the Wake Forest Institute for Regenerative Medicine and the W.H. Boyce professor and chair of the Department of Urology at Wake Forest University, spoke about regenerative medicine in four different sessions at the 13th World Stem Cell Summit in Downtown Miami. A practicing surgeon […]

Read more

Longeveron to Play Prominent Role at the World Stem Cell Summit in Miami

MIAMI, Jan. 22, 2018 /PRNewswire/ — Longeveron LLC, regenerative medicine company, announced that it will help roll out the red carpet when investigators from around the globe converge on the company’s hometown of Miami for the 2018 World Stem Cell Summit, January 22-26 at the Hyatt Regency. Longeveron Co-Founder and Chief Science Officer Joshua M. […]

Read more

Aging Frailty with Influenza Vaccine Trial announced by Longeveron

America is facing one of the worst influenza seasons in recent history. The influenza virus is one of the top ten causes of death in elderly people. Longeveron is conducting a multi-center, randomized, placebo controlled trial using its Longeveron Mesenchymal Stem Cells (LMSCs) to measure the safety of treatment with LMSCs to improve vaccine response […]

Read more

Longeveron Alzheimer’s Disease Trial

Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients with Alzheimer’s Disease. Longeveron’s Phase I, prospective, randomized, placebo-controlled, double-blinded study is designed to test the safety and efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) for the treatment of subjects with clinically diagnosed Alzheimer’s disease. Longeveron has completed the FDA mandated safety run in and […]

Read more

Longeveron Aging Frailty Phase 2b Trial

Longeveron is currently enrolling subjects in its Phase 2b multi-center clinical trial designed to test the safety and efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) for the treatment of subjects with clinically diagnosed with Aging Frailty. This is the only known trial in the world underway to use MSCs to treat Aging Frailty. Frailty is […]

Read more

Avalon GloboCare Corp. CEO David Jin, M.D., Ph.D. to Present and Chair the “China’s Impact on The World of Regenerative Medicine” Session at the 13th Annual World Stem Cell Summit

PRESS RELEASE Marketwired Jan. 21, 2018, 08:20 AM FREEHOLD, NJ (Marketwired – January 21, 2018) – Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that President and Chief Executive Officer David Jin, M.D., Ph.D. will chair a session entitled, “China’s impact on the world of regenerative medicine,” and provide […]

Read more

Mayo Clinic Center for Regenerative Medicine at the 2018 World Stem Cell Summit

The Mayo Clinic Center for Regenerative Medicine is a co-organizer of the 2018 World Stem Cell Summit. More than 1,000 attendees are expected at the 13th annual event Jan. 22-26 in Miami, Florida. Researchers and clinical experts from Mayo Clinic will participate in presentations and panel discussions highlighting advances in discovery science, promising clinical trials […]

Read more

California’s Stem Cell Agency Invests in Phase 3 Clinical Trial to Help Kidney Transplant Patients

Posted: January 18, 2018 January 18, 2018 – Oakland, CA   Over 650,000 Americans suffer from end-stage kidney disease – a life-threatening condition caused by the loss of kidney function. The best available treatment for these patients is a kidney transplant from a genetically matched, living donor. However, patients who receive a transplant must take life-long […]

Read more
The Making of a Stem Cell Super-Ecosystem with Bernard Siegel

The Making of a Stem Cell Super-Ecosystem with Bernard Siegel

January 17, 2018 By Cade Hildreth (CEO) Leave a Comment I am honored to share this interview with Bernard Siegel, Executive Director of the Regenerative Medicine Foundation (RMF), a global network of stakeholders that fosters collaboration across the industry. Bernard is also the Founder and Chair of the World Stem Cell Summit (WSCS), my favorite […]

Read more